Carbon Monoxide Inhibits the Expression of Proteins Associated with Intestinal Mucosal Pyroptosis in a Rat Model of Sepsis Induced by Cecal Ligation and Puncture.
Animals
Carbon Monoxide
/ metabolism
Caspase 1
/ metabolism
Cecum
Cytokines
/ metabolism
Disease Models, Animal
Intestinal Mucosa
/ metabolism
Intestines
/ surgery
Ligation
/ methods
Male
Punctures
/ methods
Pyroptosis
/ drug effects
Rats
Rats, Sprague-Dawley
Sepsis
/ drug therapy
Tumor Necrosis Factor-alpha
/ metabolism
Journal
Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063
Informations de publication
Date de publication:
30 Apr 2020
30 Apr 2020
Historique:
entrez:
1
5
2020
pubmed:
1
5
2020
medline:
5
1
2021
Statut:
epublish
Résumé
BACKGROUND Carbon monoxide (CO) has anti-inflammatory effects and protects the intestinal mucosal barrier in sepsis. Pyroptosis, or cell death associated with sepsis, is mediated by caspase-1 activation. This study aimed to investigate the role of CO on the expression of proteins associated with intestinal mucosal pyroptosis in a rat model of sepsis induced by cecal ligation and puncture (CLP). MATERIAL AND METHODS The rat model of sepsis was developed using CLP. Male Sprague-Dawley rats (n=120) were divided into six study groups: the sham group (n=20); the CLP group (n=20); the hemin group (treated with ferric chloride and heme) (n=20); the zinc protoporphyrin IX (ZnPPIX) group (n=20); the CO-releasing molecule 2 (CORM-2) group (n=20); and the inactive CORM-2 (iCORM-2) group (n=20). Hemin and CORM-2 were CO donors, and ZnPPIX was a CO inhibitor. In the six groups, the seven-day survival curves, the fluorescein isothiocyanate (FITC)-labeled dextran 4000 Da (FD-4) permeability assay, levels of intestinal pyroptosis proteins caspase-1, caspase-11, and gasdermin D (GSDMD) were measured by confocal fluorescence microscopy. Proinflammatory cytokines interleukin (IL)-18, IL-1ß, and high mobility group box protein 1 (HMGB1) were measured by Western blot and enzyme-linked immunosorbent assay (ELISA). RESULTS CO reduced the mortality rate in rats with sepsis and reduced intestinal mucosal permeability and mucosal damage. CO also reduced the expression levels of IL-18, IL-1ß, and HMGB1, and reduced pyroptosis by preventing the cleavage of caspase-1 and caspase-11. CONCLUSIONS In a rat model of sepsis induced by CLP, CO had a protective role by inhibiting intestinal mucosal pyroptosis.
Identifiants
pubmed: 32351244
pii: 920668
doi: 10.12659/MSM.920668
pmc: PMC7207005
doi:
Substances chimiques
Cytokines
0
Tumor Necrosis Factor-alpha
0
Carbon Monoxide
7U1EE4V452
Caspase 1
EC 3.4.22.36
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e920668Références
Nat Immunol. 2010 Dec;11(12):1136-42
pubmed: 21057511
PLoS One. 2015 Dec 31;10(12):e0145988
pubmed: 26720630
J Neuroinflammation. 2018 Apr 26;15(1):124
pubmed: 29699567
Nat Commun. 2014;5:3209
pubmed: 24492532
Sheng Li Xue Bao. 2018 Apr 25;70(2):115-122
pubmed: 29691575
Science. 2013 Sep 13;341(6151):1246-9
pubmed: 23887873
Mol Med. 2015 Oct 27;21 Suppl 1:S6-S12
pubmed: 26605648
Am J Physiol Cell Physiol. 2009 Mar;296(3):C422-32
pubmed: 19118162
J Hepatol. 2018 Apr;68(4):773-782
pubmed: 29273476
EMBO J. 2016 Aug 15;35(16):1766-78
pubmed: 27418190
J Cell Biol. 2000 May 1;149(3):613-22
pubmed: 10791975
Acute Med Surg. 2014 Apr 23;1(3):127-134
pubmed: 29930836
Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10642-10647
pubmed: 28928145
Basic Res Cardiol. 2017 Mar;112(2):16
pubmed: 28168403
Crit Care Med. 2007 Apr;35(4):1055-60
pubmed: 17334238
Trends Microbiol. 2001 Mar;9(3):113-4
pubmed: 11303500
PLoS Pathog. 2013;9(6):e1003400
pubmed: 23762026
Antioxid Redox Signal. 2014 Jan 20;20(3):432-42
pubmed: 23971531
J Hepatol. 2017 May;66(5):1037-1046
pubmed: 28167322
J Pharmacol Exp Ther. 2009 May;329(2):641-8
pubmed: 19190234
Zhonghua Yi Xue Za Zhi. 2016 Nov 29;96(44):3568-3572
pubmed: 27916077
Nature. 2016 Jul 06;535(7610):153-8
pubmed: 27383986
Nihon Yakurigaku Zasshi. 2018;151(1):4-8
pubmed: 29321395
PLoS Pathog. 2013 Feb;9(2):e1003144
pubmed: 23468620
Curr Opin Microbiol. 2013 Jun;16(3):319-26
pubmed: 23707339
Cell Death Differ. 2007 Sep;14(9):1590-604
pubmed: 17599095
J Med Chem. 2018 Apr 12;61(7):2611-2635
pubmed: 28876065
Mol Med. 2014 Mar 24;20:138-46
pubmed: 24531836
Nat Rev Microbiol. 2009 Feb;7(2):99-109
pubmed: 19148178
Mol Med. 2006 Apr-Jun;12(4-6):105-14
pubmed: 16953558
Cell Death Dis. 2018 May 22;9(6):597
pubmed: 29789550
PLoS Pathog. 2018 May 23;14(5):e1007105
pubmed: 29791511
Nat Commun. 2018 Mar 8;9(1):996
pubmed: 29520027
Gut. 1999 Aug;45(2):223-8
pubmed: 10403734
Eur J Pharmacol. 2018 Jan 5;818:57-66
pubmed: 29055786
Shock. 2009 Oct;32(4):348-57
pubmed: 19333143
J Control Release. 2018 Jun 10;279:336-344
pubmed: 29655987
JAMA. 2016 Feb 23;315(8):775-87
pubmed: 26903336
Crit Care Med. 2003 Jun;31(6):1630-7
pubmed: 12794397
Cell Microbiol. 2006 Nov;8(11):1812-25
pubmed: 16824040
Immunol Rev. 2015 May;265(1):130-42
pubmed: 25879289
Int J Mol Sci. 2015 Aug 31;16(9):20595-608
pubmed: 26334271
Arch Surg. 1970 Oct;101(4):478-83
pubmed: 5457245
Nature. 2015 Oct 29;526(7575):666-71
pubmed: 26375259
Lab Invest. 2018 Aug;98(8):1052-1064
pubmed: 29884910
Immunol Today. 2000 Mar;21(3):123-8
pubmed: 10689299
Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):107-117
pubmed: 29456024
PLoS Pathog. 2014 Aug 28;10(8):e1004327
pubmed: 25166912
Am J Physiol Lung Cell Mol Physiol. 2015 Dec 15;309(12):L1387-93
pubmed: 26498251
Am J Pathol. 2014 Nov;184(11):2965-75
pubmed: 25204845
Nature. 2015 Oct 29;526(7575):660-5
pubmed: 26375003
Br Med Bull. 1999;55(1):196-211
pubmed: 10695087
Science. 2013 Sep 13;341(6151):1250-3
pubmed: 24031018
World J Gastroenterol. 2012 Oct 28;18(40):5719-28
pubmed: 23155312
Toxicol Lett. 2016 Mar 30;246:7-16
pubmed: 26809137
Shock. 2016 Jul;46(1):52-9
pubmed: 27299587